---

---

entities : Viatris inc.    symbols : VTRS   

save search

---

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-16 (Crawled : 21:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -0.18% | O: 0.63% H: 0.54% C: -0.8%
first report financial results

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -1.94% | O: -0.53% H: 0.0% C: -1.24%
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
PHG | News | $20.15 -0.89% -0.6% 960 |

Health Technology

| -2.52% | O: -1.21% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% -0.05% 8.7K |

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $16.11 -1.77% 25K |

Health Technology

| 3.8% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

---

Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Published: 2024-04-15 (Crawled : 12:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -2.03% | O: 0.88% H: 1.84% C: -0.96%
commercial

---

Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | $11.15 0.45% 77K |

Health Technology

| -4.06% | O: -0.17% H: 0.17% C: -1.9%
RVNC | $3.76 -1.31% -1.87% 280 |

Health Technology

| -16.07% | O: -2.01% H: 1.37% C: -5.92%
daxxify neurology meeting

---

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | News | $9.594 1.2% 43.47% 5.4K |

Health Technology

| -10.96% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 0.63% -2.18% 0 |

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -2.16% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | News | $9.46 1.29% -1.11% 0 |

Manufacturing

| -10.79% | O: -0.29% H: 0.0% C: -1.97%
VTRS | $11.15 0.45% 77K |

Health Technology

| -5.29% | O: -0.6% H: 1.03% C: 0.52%
TMO | News | $547.25 -1.32% -3.72% 3.4K |

Health Technology

| -7.12% | O: -2.01% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| -2.71% | O: -1.16% H: 0.0% C: 0.0%
SNY | News | $46.11 0.68% 0.7% 66K |

Health Technology

| -2.99% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | News | $107.1 -1.65% -1.63% 0 |

Health Technology

| -7.38% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

---

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 0 |

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $140.15 3.58% 0 |

Health Technology

| 1.57% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.15 0.45% 77K |

Health Technology

| -5.93% | O: -0.25% H: 1.1% C: -0.17%
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| -2.83% | O: -0.05% H: 0.43% C: -0.27%
BMY | $47.84 370K |

Health Technology

| -5.96% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.66 -0.92% 0.0% 93 |

Health Technology

| -16.04% | O: 0.38% H: 0.0% C: -7.27%
ABBV | $165.45 0.73% 140K |

Health Technology

| -2.38% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.11 0.68% 0.7% 66K |

Health Technology

| -1.74% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 4.3K |

Health Technology

| 1.21% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

---

Contraceptive Market Projected to Reach $119.89 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-03 (Crawled : 02:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -7.04% | O: -0.42% H: 2.78% C: 1.09%
SNY | News | $46.11 0.68% 0.7% 66K |

Health Technology

| -3.33% | O: 0.69% H: 0.0% C: 0.0%
report reach contraceptive market

---

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -6.49% | O: 0.84% H: 0.0% C: -0.25%
OCUP | $1.74 0.29% 0 |

Health Technology

| -13.0% | O: 1.0% H: 10.4% C: 10.4%
solution commercial ryzumvl apx3330

---

Idorsia and Viatris successfully close the transaction for the global research and development collaboration
Published: 2024-03-18 (Crawled : 06:00) - globenewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -7.04% | O: -0.59% H: 0.59% C: -0.93%
research global collaboration

---

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
Published: 2024-03-11 (Crawled : 14:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -9.46% | O: -0.82% H: 0.7% C: -1.56%
acquired

---

Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 17:00) - biospace.com/
VTRS | $11.15 0.45% 77K |

Health Technology

| -11.83% | O: 0.0% H: 0.08% C: -1.83%
RVNC | $3.76 -1.31% -1.87% 280 |

Health Technology

| -46.13% | O: -11.6% H: 3.89% C: -1.62%
million offering

---

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
Published: 2024-02-28 (Crawled : 06:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -16.1% | O: -0.15% H: 2.57% C: -6.96%
research global collaboration

---

Idorsia and Viatris enter into a significant global research and development collaboration
Published: 2024-02-28 (Crawled : 06:00) - globenewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -16.1% | O: -0.15% H: 2.57% C: -6.96%
research global collaboration

---

Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -16.1% | O: -0.15% H: 2.57% C: -6.96%
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| -9.76% | O: 0.05% H: 0.06% C: -0.95%
JNJ | News | $144.77 0.22% 0.4% 130K |

Health Technology

| -9.52% | O: 0.67% H: 0.0% C: 0.0%
ABT | News | $106.43 0.5% 320K |

Health Technology

| -8.67% | O: 1.12% H: 0.52% C: 0.47%
report india global market

---

Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| -8.97% | O: 0.37% H: 0.58% C: 0.58%
VTRS | $11.15 0.45% 77K |

Health Technology

| -16.92% | O: 0.0% H: 1.93% C: 1.27%
NVO | News | $124.53 0.88% -1.1% 22K |

Health Technology

| 0.01% | O: -0.68% H: 0.4% C: -0.18%
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| -9.46% | O: 0.89% H: 0.4% C: 0.17%
JNJ | News | $144.77 0.22% 0.4% 130K |

Health Technology

| -9.77% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $46.11 0.68% 0.7% 66K |

Health Technology

| -3.77% | O: 0.97% H: 0.0% C: 0.0%
report revenue global insulin growth market

---

Binge-eating Disorder Treatment Market Research Report 2024
Published: 2024-02-23 (Crawled : 02:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -16.92% | O: 0.0% H: 1.93% C: 1.27%
TNXP | $0.1594 6.34% 5.19% 120K |

Health Technology

| -49.43% | O: 0.0% H: 4.3% C: 1.77%
report treatment research market

---

Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024
Published: 2024-02-21 (Crawled : 15:30) - biospace.com/
VTRS | $11.15 0.45% 77K |

Health Technology

| -16.16% | O: -0.15% H: 0.76% C: 0.3%
RVNC | $3.76 -1.31% -1.87% 280 |

Health Technology

| -31.76% | O: 0.18% H: 0.72% C: -2.72%
year financial results

---

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $192.16 -1.53% -1.57% 350 |

Health Technology

| Email alert Add to watchlist
VTRS | $11.15 0.45% 77K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
AZN | $68.53 0.39% 0.39% 4.3K |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| Email alert Add to watchlist
GSK | $39.6 -0.88% -0.05% 8.7K |

Health Technology

| Email alert Add to watchlist
AZNCF | $140.15 3.58% 0 |

Health Technology

| Email alert Add to watchlist
JAZZ | News | $107.1 -1.65% -1.63% 0 |

Health Technology

| Email alert Add to watchlist
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| Email alert Add to watchlist
AMGN | $264.07 -0.59% -0.59% 350 |

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

---

Intrauterine Contraceptive Devices (IUD) Market to grow by USD 965.49 million at a CAGR of 3.98% from 2022 to 2027, AbbVie Inc. and Bayer AG are among the key companies - Technavio
Published: 2024-02-08 (Crawled : 06:00) - prnewswire.com
VTRS | $11.15 0.45% 77K |

Health Technology

| -5.45% | O: -0.34% H: 0.0% C: -1.2%
ABBV | $165.45 0.73% 140K |

Health Technology

| -5.54% | O: 0.5% H: 0.0% C: 0.0%
ABT | News | $106.43 0.5% 320K |

Health Technology

| -5.72% | O: -1.41% H: 0.0% C: 0.0%
companies abbvie million contraceptive key market

---

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0006 620K |

n/a

| 471.43% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | News | $92.7 0.63% -2.18% 0 |

Health Technology

| -1.05% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.15 0.45% 77K |

Health Technology

| -5.45% | O: -0.34% H: 0.0% C: -1.2%
NVS | News | $93.08 -0.13% -0.04% 670 |

Health Technology

| -10.03% | O: -1.57% H: 0.26% C: -0.47%
GSK | $39.6 -0.88% -0.05% 8.7K |

Health Technology

| -5.76% | O: -0.48% H: 0.16% C: 0.0%
BAX | News | $39.52 -0.13% 0.0% 2 |

Health Technology

| 0.81% | O: -0.96% H: 5.91% C: 3.74%
ABT | News | $106.43 0.5% 320K |

Health Technology

| -5.72% | O: -1.41% H: 0.0% C: 0.0%
SNY | News | $46.11 0.68% 0.7% 66K |

Health Technology

| -2.21% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $264.07 -0.59% -0.59% 350 |

Health Technology

| -9.78% | O: 0.38% H: 0.34% C: -0.72%
america growth market

---

Gainers vs Losers

48%

52%

Top 10 Gainers

AGBA | $1.44 260.0% 40M |

Finance

BPTH | $6.25 92.9% 20M |

Health Technology

EGOX | $0.0447 39.25% 24M |

BNTC | $5.91 23.13% 1.3M |

Health Technology

XPON | $2.33 20.73% 410K |

BRSH | $0.0515 15.99% 12M |

n/a

VTNR S | $1.12 14.38% 470K |

Industrial Services

DXYZ 4 | $33.49 13.41% 210K |

n/a

BMI 4 | $169.84 11.01% 68K |

Producer Manufacturing

CTM | $0.244 10.86% 40K |

n/a

---

Your saved searches

---